source
- Caspian Therapeutics launches with $50M funding and Eli Lilly backing to develop menin inhibitor for diabetesCaspian Therapeutics has been created as a spin-out from Kura Oncology to advance a menin-targeting drug for diabetes. The company received $50 million in initial capital, led by BVF Partners with…
- Kura Oncology launches Caspian Therapeutics with $50M funding to develop next-generation diabetes drugKura Oncology has created a new biotech called Caspian Therapeutics and secured $50 million in financing to advance a next-generation diabetes treatment. The spinout will focus on KO-7246, a highl…